NLRC4 and neoplasm: Multiple inflammasomes, including NLRP3, NLRC4, NLRP1, and AIM2, may inhibit tumor initiation by influencing innate and adaptive immunity, apoptosis, and differentiation (Di Virgilio, 2013).